Rafferty Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121K | Buy |
25,903
+10,900
| +73% | +$50.9K | ﹤0.01% | 1066 |
|
|
2025
Q1 | $82.4K | Sell |
15,003
-2,717
| -15% | -$14.9K | ﹤0.01% | 1049 |
|
|
2024
Q4 | $60.1K | Sell |
17,720
-1,392
| -7% | -$4.72K | ﹤0.01% | 1137 |
|
|
2024
Q3 | $54.5K | Sell |
19,112
-424
| -2% | -$1.21K | ﹤0.01% | 1136 |
|
|
2024
Q2 | $44K | Sell |
19,536
-1,677
| -8% | -$3.77K | ﹤0.01% | 1168 |
|
|
2024
Q1 | $46.9K | Buy |
+21,213
| New | +$46.9K | ﹤0.01% | 1078 |
|
|
2022
Q3 | – | Sell |
-35,248
| Closed | -$54K | – | 1260 |
|
|
2022
Q2 | $54K | Buy |
35,248
+4,105
| +13% | +$6.29K | ﹤0.01% | 1098 |
|
|
2022
Q1 | $80K | Sell |
31,143
-12,198
| -28% | -$31.3K | ﹤0.01% | 1189 |
|
|
2021
Q4 | $127K | Buy |
43,341
+14,174
| +49% | +$41.5K | ﹤0.01% | 1246 |
|
|
2021
Q3 | $71K | Buy |
+29,167
| New | +$71K | ﹤0.01% | 1248 |
|